在前性痴呆症中出现并发性:它们告诉我们什么?
Syeda Amrah Hashmi1, Mark Quigg1, Anelyssa D'Abreu1
1Department of Neurology, University of Virginia School of Medicine, Charlottesville, VA, United States.
Epilepsy research
|August 20, 2025
概括
前性痴呆症 (FTD) 患者患有并发作,通常是行为变异性FTD (bvFTD),患病率为7. 6%. 创伤性脑损伤是主要的危险因素,大多数患者通过抗发作药物 (ASM) 控制发作.
科学领域:
- 神经学
- 神经科学
- 临床医学
背景情况:
- 在前性痴呆 (FTD) 患者中,并发性发作影响2至11%.
- 没有研究过FTD的风险因素,临床特征和结局.
研究的目的:
- 研究FTD患者的发作发病率,风险因素,临床特征和结果.
- 确定与相关的特定FTD亚型和并发症.
主要方法:
- 在2011年5月1日至2024年4月30日期间诊断的317名FTD患者的回顾性分析.
- 患者被分为bvFTD,svPPA或nfPPA,并被分为有的FTD (FTD+SZ) 或没有的FTD (FTD-SZ).
- 从电子医疗记录中提取了人口统计,并发病,痴呆和特征的数据;统计分析包括基平方测试,费舍尔精确测试和t测试.
主要成果:
- 7. 6% 的FTD患者 (24/317) 患有发作 (FTD+SZ).
- 创伤性脑损伤 (TBI) 是一个显著的风险因素 (p < 0. 001);焦虑在FTD+SZ中更为普遍 (p=0. 0392).
- 行为变异性FTD (bvFTD) 是最常见的亚型;焦点,特别是叶 (TLE),占主导地位. 通过抗发作药物 (ASM) 控制了发作的87. 5%.
结论:
- 这项研究发现FTD中发作的患病率为7. 6%,主要是bvFTD,特征是焦点发作 (TLE).
- 焦虑和TBI与有关,ASM通常可以很好地控制.
- 患有FTD的患者在死亡时年龄较大,这凸显了对诊断和治疗的进一步研究的需要.
更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.8K
12:09Network Analysis of the Default Mode Network Using Functional Connectivity MRI in Temporal Lobe Epilepsy
Published on: August 5, 2014
18.1K
相关概念视频
01:13Seizures: Classification
586
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
586
01:24Epilepsy and Seizures: Overview
277
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
277
01:30Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:15Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703